What are metamyelocytes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metamyelocytes: An Intermediate Stage in Granulocyte Development

Metamyelocytes are immature granulocytes that represent an intermediate stage in neutrophil development, occurring between myelocytes and band neutrophils in the maturation process of granulocytic cells. They are normally found in the bone marrow but may appear in peripheral blood during certain pathological conditions.

Characteristics of Metamyelocytes

  • Morphology: Metamyelocytes have a kidney-shaped or indented nucleus (unlike the round nucleus of myelocytes) but have not yet developed the band or segmented form of mature neutrophils
  • Size: Generally 10-15 μm in diameter
  • Location: Primarily found in bone marrow during normal hematopoiesis
  • Development sequence: Myeloblast → Promyelocyte → Myelocyte → Metamyelocyte → Band neutrophil → Segmented neutrophil

Clinical Significance

Presence in Peripheral Blood

The appearance of metamyelocytes in peripheral blood (along with other immature granulocytes) is referred to as a "left shift" and indicates increased bone marrow activity 1. This can occur in:

  • Infections and inflammatory conditions
  • Leukemic processes
  • Myeloproliferative disorders
  • Bone marrow recovery after chemotherapy or radiation

Diagnostic Value

  1. Chronic Myeloid Leukemia (CML): The hallmark of CML diagnosis includes leukocytosis with immature granulocytes in peripheral blood, primarily metamyelocytes, myelocytes, and promyelocytes 1. This is a key diagnostic feature that helps distinguish CML from other myeloproliferative disorders.

  2. Inflammatory Response: Increased metamyelocyte counts in peripheral blood can serve as a biomarker for enhanced bone marrow activity in response to infection or inflammation 2.

  3. Prognostic Indicator: In some hematologic malignancies, the presence of a left shift (including metamyelocytes) at diagnosis has been correlated with disease outcomes 3.

Identification Methods

Microscopic Examination

  • Light microscopy with Wright-Giemsa stain is the traditional method for identifying metamyelocytes in bone marrow aspirates or peripheral blood smears

Flow Cytometry

  • Modern flow cytometric methods can enumerate and classify immature granulocytes including metamyelocytes
  • Metamyelocytes can be identified as CD16-/CD11b+ cells (IG stage 2) 4

Pathological Implications

Vitamin Deficiencies

  • In vitamin B12 and folate deficiency, giant metamyelocytes may appear, representing abnormal development of granulocyte precursors 5

Myelodysplastic Syndromes

  • Dysplastic metamyelocytes may be observed in myelodysplastic syndromes, showing abnormal nuclear configuration or granulation 1

Biological Role

Metamyelocytes represent a critical stage in neutrophil maturation where:

  • The nucleus begins to change from round to indented shape
  • Specific granules continue to form
  • The cell loses its capacity for division (unlike earlier precursors such as myelocytes)
  • The cell continues to develop the enzymatic and functional capabilities needed for mature neutrophil function 6

In summary, metamyelocytes are important intermediate cells in granulocyte development that normally reside in bone marrow. Their appearance in peripheral blood serves as an important diagnostic and prognostic indicator in various hematological and inflammatory conditions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.